Information

15.06.2024

Simplification of requirements for renewed authorisation of medicinal products

Swissmedic has simplified the requirements for renewed authorisation of medicinal products

01.06.2024

Changes to the Guidance document Variations and extensions HAM

Simplification of rules on issuing new packaging codes and elimination of subsumption of fees for multiple applications

01.06.2024

Changes to the Guidance document Meetings for applicants for authorisation procedures

Preliminary Decision Clarification Meeting introduced as a pilot

01.06.2024

Changes to the Guidance document Temporary authorisation of human medicinal products

Swissmedic clarifies the scope for temporary authorisations of human medicinal products

01.06.2024

Changes to the Guidance document Time limits for authorisation applications

The revised Guidance document Time limits for authorisation applications is valid with effect from 1 June 2024.

12.02.2024

Authorisations of human medicinal products with a new active substance and additional indications 2023

41 human medicinal products with new active substances authorised

01.02.2024

Voluntary prior notification of new applications with new active substance for human medicinal products

Prior notification of a new application with a new active substance enables Swissmedic to plan resources early on and supports efficient processing of applications

15.01.2024

Changes to guidance document Authorisation of human medicinal product with known active pharmaceutical ingredient

Medicinal products whose known chemical active pharmaceutical ingredient has a complex, heterogeneous structure may be deemed to be medicinal products with a known active pharmaceutical ingredient (known API, with or without innovation)

15.01.2024

Changes to the guidance document Temporary authorisation of human medicinal products

Clarification of the term "equivalent medicinal product" and timing of criteria assessment for temporary authorisation

15.01.2024

Changes to the Guidance document Fast-track authorisation procedure

Optimisation of the application procedure for the implementation of a fast-track authorisation procedure (FTP)

15.01.2024

Changes to the guidance document Authorisation of human medicinal products under Art. 13 TPA

The guidance document Authorisation of human medicinal products TPA and the form Information for application Art. 13 TPA have been revised

15.01.2024

Guidance document Authorisation according to Art. 14 para. 1 abis-quater TPA updated

Explanations regarding dispensing category classification and clarification of the requirements for the application documentation for authorisations according to Art. 14 para. 1 letter abis-quater TPA

01.01.2024

New guidance document Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)

Simplification of parallel imports of human medicinal products already authorised in Switzerland

01.10.2023

Changes to the guidance document Mobile technologies and the related form

Training documents according to the most recently approved RMP are considered to be information required by therapeutic products legislation